"Harnessing genomics to improve health in Africa" – an executive course to support genomics policy

Abstract

BackgroundAfrica in the twenty-first century is faced with a heavy burden of disease, combined with ill-equipped medical systems and underdeveloped technological capacity. A major challenge for the international community is to bring scientific and technological advances like genomics to bear on the health priorities of poorer countries. The New Partnership for Africa's Development has identified science and technology as a key platform for Africa's renewal. Recognizing the timeliness of this issue, the African Centre for Technology Studies and the University of Toronto Joint Centre for Bioethics co-organized a course on Genomics and Public Health Policy in Nairobi, Kenya, the first of a series of similar courses to take place in the developing world. This article presents the findings and recommendations that emerged from this process, recommendations which suggest that a regional approach to developing sound science and technology policies is the key to harnessing genome-related biotechnology to improve health and contribute to human development in Africa.MethodsThe objectives of the course were to familiarize participants with the current status and implications of genomics for health in Africa; to provide frameworks for analyzing and debating the policy and ethical questions; and to begin developing a network across different sectors by sharing perspectives and building relationships. To achieve these goals the course brought together a diverse group of stakeholders from academic research centres, the media, non-governmental, voluntary and legal organizations to stimulate multi-sectoral debate around issues of policy. Topics included scientific advances in genomics innovation systems and business models, international regulatory frameworks, as well as ethical and legal issues.ResultsSeven main recommendations emerged: establish a network for sustained dialogue among participants; identify champions among politicians; use the New Plan for African Development (NEPAD) as entry point onto political agenda; commission an African capacity survey in genomics-related R&D to determine areas of strength; undertake a detailed study of R&D models with demonstrated success in the developing world, i.e. China, India, Cuba, Brazil; establish seven regional research centres of excellence; and, create sustainable financing mechanisms. A concrete outcome of this intensive five-day course was the establishment of the African Genome Policy Forum, a multi-stakeholder forum to foster further discussion on policy.ConclusionWith African leaders engaged in the New Partnership for Africa's Development, science and technology is well poised to play a valuable role in Africa's renewal, by contributing to economic development and to improved health. Africa's first course on Genomics and Public Health Policy aspired to contribute to the effort to bring this issue to the forefront of the policy debate, focusing on genomics through the lens of public health. The process that has led to this course has served as a model for three subsequent ...

How can developing countries harness biotechnology to improve health?

“…The general consensus reflected success in terms of achieving the goals and objectives of the Courses, with satisfaction ratings by the participants ranging from 86%-96%. The first three courses have been published individually without a synthesis of the recommendations as a whole [ 14 - 16 ]. This paper, however, compares and analyzes recommendations from all five courses.…”

Capacity building for whole genome sequencing of Mycobacterium tuberculosis and bioinformatics in high TB burden countries

“…Bringing the scientific and technological advances of genomics to resource-poor countries in a way that is relevant to the local health priorities poses a major challenge [ 11 , 12 ]. Establishing WGS facilities requires investment in human, laboratory and computational infrastructure [ 5 ].…”

Taking Stock of the Ethical Foundations of International Health Research: Pragmatic Lessons from the IU–Moi Academic Research Ethics Partnership

“…1 Over the last 5 years, a comprehensive literature in global bioethics has emerged providing ever-more-detailed assessments of informed consent, 2 the conduct of clinical trials, 3 ethics review of research, 4 post-trial obligations to research participants 5 and other more specialized topics in genomics, 6,7 public health, 8,9 sustainability, 10 community engagement, 11 and the deployment of biotechnology. 12 Research and health care provided in international settings raise profound ethical questions when different cultural and political values are involved.…”